Calcium channel blocker: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
{{Drug List/ja}}
{{Drug List/ja}}
{{Pathnav|Medication/ja|Antihypertensive drug/ja}}
{{Pathnav|Medication/ja|Antihypertensive drug/ja|frame=1}}


{| class="wikitable sortable" style="width:100%"
|+[[Dihydropyridine/ja|ジヒドロビリジン系]]
|-
!一般名
!先発名
!class="unsortable"| 日本
!開発
!備考
|-
|[[Amlodipine/ja]]
|ノルバスク(Norvasc) ([https://pins.japic.or.jp/pdf/newPINS/00058792.pdf PI]) ([https://www.viatris-e-channel.com/viatris-products/di/pdf/nor01if.pdf IF])
|○
|[[Pfizer]]
|
|-
|[[Aranidipine/ja]]
|サプレスタ(Sapresta) ([https://s3-ap-northeast-1.amazonaws.com/medley-medicine/prescriptionpdf/400107_2149038D1044_1_04.pdf PI] [https://image.packageinsert.jp/pdf.php?mode=1&yjcode=2149038D1044 IF])
|
|[[:ja:日医工|マルコ製薬]]<br />[[:ja:大鵬薬品工業|大鵬薬品]]
|
|-
|}
<languages />
<languages />
<translate>
<translate>